Clinical Outcomes of Upper Gastrointestinal Bleeding in Egyptian Patients with Decompensated Liver Cirrhosis, Does the Bleeding Source Matter?

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: The Egyptian Journal of Hospital Medicine Ain Shams University Volume:
Keywords : Clinical Outcomes , Upper Gastrointestinal Bleeding , Egyptian    
Abstract:
ABSTRACT Background: Upper gastrointestinal bleeding (UGIB) is a prevalent emergency and mortality cause in cirrhotic patients. It prolongs the hospital length of stay (LOS) and increases hospital readmission. Objectives: We investigated the clinical outcomes of acute variceal bleeding (AVB) and non-variceal bleeding (NVB) in patients with decompensated cirrhosis and the possible risk factors for prolonged hospital LOS. Patients and Methods: All patients with decompensated liver cirrhosis and UGIB (AVB & NVB) hospitalized from August 2018 to March 2019 were enrolled in this study. We assessed mortality rate, the hospital LOS and hospital readmission rate along with the probable risk factors associated with prolonged hospital LOS. Results: Our study included 582 patients with decompensated liver cirrhosis, 367 patients had AVB and 215 patients had NVB. There was no significant difference in mortality rate between both groups (11.4% vs. 9.3%, P= 0.43). The hospital LOS in AVB patients was longer than that in NVB group (5.8 ± 2.2 vs. 4.3 ± 1.8, p=0.001). Rate of hospital re-admission within 30 days was significantly higher in the AVB group (27%) compared to NVB group (18%). In-hospital re-bleeding and the need for repeated endoscopy were also higher in AVB patients (20%) than in NVB patients (12%). Risk factors for prolonged hospital LOS were development of hepatic encephalopathy, spontaneous bacterial peritonitis (SBP), in-hospital re-bleeding, Child C score and higher Model for end-stage liver Conclusion: Patients with decompensated cirrhosis and AVB have longer hospital LOS and re-hospitalization rate than those with NVB with no significant difference in mortality rate between both groups.disease (MELD) score.
   
     
 
       

Author Related Publications

  • Mohammed Jaber Hamid, "أثر الأرتفاع الحاد بنسبة السكر بالدم و أسلوب التعامل معه على النتائج قصيرة المدى فى مرضى الحالات الحرجة الباطنة و الجراحية بمستشفيات جامعة الزقازيق", جامعة القاهرة, 2015 More
  • Mohammed Jaber Hamid, "Uropathogens Among Diabetic Patients At Zagazig University Hospital’s Outpatient Clinics: Prevalence And Their Antibiotic Susceptibility Patterns", Zagazig University Medical Journal, 2018 More
  • Mohammed Jaber Hamid, "Association of Apolipoprotein A1 Gene Polymorphism and Coronary Heart Diseases in Patients with Type 2 Diabetes Mellitus", Ain Shams University, 2021 More
  • Mohammed Jaber Hamid, "Study of plasma klotho and plasma copeptin level in adolescents with type 1 diabetes mellitus and relation to microvascular complications", Wolters Kluwer - Medknow, 2021 More
  • Mohammed Jaber Hamid, "Evaluation of perceived fears of COVID‑19 virus infection and its relationship to health‑related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single‑center study", Springer, 2021 More

Department Related Publications

  • Mohammed Sallam Suleiman Saad, "Role of MicroRNA 126 in Screening, Diagnosis, and Prognosis of Diabetic Patients in Egypt", wiley, 2016 More
  • Mohamed Essam El Din Ahmd, "Effect of aerobic exercises on blood coagulation and fibrinolytic system in type 2 diabetic patients", International Journal of Advanced research (2015), Volume 3, Issue 5,64-70, 2015 More
  • Nafisa Mohamed KamalElDin, "Prevalence and effect of SEN virus in hemodialysis patients in Zagazig university nephrology unit", on line, 2016 More
  • Huda Abdul Aziz Hadi Ahmad, "Evaluation of Some Non Invasive Predictors for Presence of Esophageal Varices in Patients with Compensated HCV Positive Cirrhosis", International Journal of Science and Research (IJSR), 2016 More
  • Hazem Mohamed Aleshmawi Soliman, "Association of serum podocalyxin levels with peripheral arterial disease in patients with type 2 diabetes", Elsevier, 2019 More
Tweet